EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functions of glutaminyl cyclase and its isoform in diseases

Yu’e Liu, Yufeng Shi, Ping Wang

Visualized Cancer Medicine · 2023

DOI: 10.1051/vcm/2022008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Visualized Cancer Medicine, 2023. Verfasst von Yu’e Liu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glutaminyl cyclase (QC; isoform: isoQC) is a zinc-dependent enzyme that catalyzes the intramolecular cyclization of N-terminal glutamine and glutamic acid residues into a pyroglutamate residue (pGlu). This conversion is a type of posttranslational modification called pyroglutamylation. The expression of QC/isoQC is regulated by epigenetics, cell homeostasis, and its substrates. Pyroglutamylation is an important maturation process during the synthesis and secretion of hormones, functioning in different diseases, such as Alzheimer’s disease, tumors, and other kinds of chronic diseases mediated by inflammation. IsoQC has been identified as a key regulator of the CD47-SIRPα checkpoint and is critical for the pyroglutamylation of CD47 at its SIRPα binding site, thus helping cancer cells evade immune surveillance. Inhibition of isoQC blocks the interaction between CD47 and SIRPα, leading to constrained tumor growth, indicating that isoQC is a novel target for immunotherapy. Targeting isoQC overcomes the side effects of targeting CD47 because isoQC is Golgi resident and is not expressed on erythrocytes. Small molecules and antibodies have been developed to target isoQC, and some of them have been tested in preclinical or clinical studies. Here, we briefly review the discovery history of QC/isoQC and then discuss its regulation and function in different diseases, emphasizing the unique role of isoQC in immunotherapy. Finally, we summarize the development of inhibitors and their progress in clinical trials with the hope of providing useful insights for future investigation of QC/isoQC and targeting it in various diseases.

Zitieren

APA

Liu, Y., Shi, Y., & Wang, P. (2023). Functions of glutaminyl cyclase and its isoform in diseases. Visualized Cancer Medicine. https://doi.org/10.1051/vcm/2022008

Vancouver

Liu Y, Shi Y, Wang P. Functions of glutaminyl cyclase and its isoform in diseases. Visualized Cancer Medicine. 2023. doi:10.1051/vcm/2022008

BibTeX
@article{Liu2023,
  author = {Liu, Yu’e and Shi, Yufeng and Wang, Ping},
  title = {Functions of glutaminyl cyclase and its isoform in diseases},
  journal = {Visualized Cancer Medicine},
  year = {2023},
  doi = {10.1051/vcm/2022008}
}
Kostenlos starten →